This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Heintz, B. Articles by Haubeck, H.-D. Search for Related Content PubMed PubMed Citation Articles by Heintz, B. Articles by Haubeck, H.-D. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information High Blood Pressure

(Hypertension. 1995;25:399-407.)
© 1995 American Heart Association, Inc.

Articles

Decreased Glomerular Basement Membrane Heparan Sulfate Proteoglycan in Essential Hypertension

Bernhard Heintz; Georg Stöcker; Christian Mrowka; Uwe Rentz; Heinrich Melzer; Elmar Stickeler; Heinz-Günther Sieberth; Helmut Greiling; Hans-Dieter Haubeck

From the Medizinische Klinik II (B.H., C.M., U.R., H.M., H.-G.S.) and the Institut für Klinische Chemie und Pathobiochemie (G.S., E.S., H.G., H.-D.H.) der RWTH Aachen (Germany).

Correspondence to Dr med Bernhard Heintz, Medizinische Klinik II, RWTH Aachen, Pauwelsstraße 30, 52057Aachen, Germany.

Abstract Heparan sulfate proteoglycans are major components of the glomerular basement membrane and play a key role in the molecular organization and function of the basement membrane. Moreover, their presence is essential for maintenance of the selective permeability of the glomerular basement membrane. Recently, we isolated and characterized a novel small basement membrane–associated heparan sulfate proteoglycan from human aorta and kidney. Partial amino acid sequence data clearly show that this heparan sulfate proteoglycan is distinct from the large basement membrane–associated heparan sulfate proteoglycan (perlecan). Using specific monoclonal antibodies, we have shown that the novel heparan sulfate proteoglycan is located predominantly in the glomerular basement membrane and, to a lesser extent, in the basement membrane of tubuli. Turnover or, in the course of kidney diseases, degradation of heparan sulfate proteoglycan from glomerular basement membranes may lead to urinary excretion of heparan sulfate proteoglycan, which can be measured by a sensitive enzyme immunoassay. The aim of the present study was to analyze whether changes in the structure and function of glomerular basement membranes can be directly detected by measurement of the excretion of a component of this basement membrane, eg, heparan sulfate proteoglycan into urine. The excretion of this small heparan sulfate proteoglycan was compared after physical exercise in normotensive and hypertensive subjects. Normotensive subjects and treated, essential hypertensive patients underwent a standardized workload on a bicycle ergometer. Biochemical characterization of the urinary proteins and heparan sulfate proteoglycan was performed before and 15 and 45 minutes after exercise. In both groups, physical exercise induced a significant increase in the excretion of urinary 1 microglobulin and albumin. However, a 10-fold increase in the urinary excretion rate of heparan sulfate proteoglycan was seen in normotensive subjects under exercise. In hypertensive patients, the relative increase in heparan sulfate proteoglycan excretion was significantly diminished (P<.05). These data, supported by immunohistochemistry, indicate changes in the glomerular basement membrane of the kidney in hypertension. Therefore, determination of urinary excretion of this novel small heparan sulfate proteoglycan after exercise may be a sensitive marker for the detection of basement membrane alterations in hypertension.

Key Words: heparitin sulfate • hypertension, essential • proteoglycans • exercise • proteinuria

This article has been cited by other articles:

				R. E. F. Christiansen, O. Tenstad, S. Leh, and B. M. Iversen Glomerular charge selectivity is impaired in hypertensive nephropathy Nephrol. Dial. Transplant., May 1, 2004; 19(5): 1083 - 1091. [Abstract] [Full Text] [PDF]

				D. Yavuz, A. Toprak, Y. Budak, H. O. Ersoz, O. Deyneli, H. Tezcan, and S. Akalin Urinary Glycosaminoglycan Excretion in Newly Diagnosed Essential Hypertensive Patients Clin. Chem., February 1, 2000; 46(2): 299 - 301. [Full Text] [PDF]

				A. J. A. Groffen, J. H. Veerkamp, L. A. H. Monnens, and L. P. W. J. van den Heuvel Recent insights into the structure and functions of heparan sulfate proteoglycans in the human glomerular basement membrane Nephrol. Dial. Transplant., September 1, 1999; 14(9): 2119 - 2129. [Abstract] [Full Text] [PDF]